APA (7th ed.) Citation

Wigle, T. J., Povitz, B. L., Medwid, S., Teft, W. A., Legan, R. M., Lenehan, J., . . . Kim, R. B. (2021). Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events. CTS: Clinical & Translational Science, 14(4), 1338. https://doi.org/10.1111/cts.12981

Chicago Style (17th ed.) Citation

Wigle, Theodore J., et al. "Impact of Pretreatment Dihydropyrimidine Dehydrogenase Genotype‐guided Fluoropyrimidine Dosing on Chemotherapy Associated Adverse Events." CTS: Clinical & Translational Science 14, no. 4 (2021): 1338. https://doi.org/10.1111/cts.12981.

MLA (9th ed.) Citation

Wigle, Theodore J., et al. "Impact of Pretreatment Dihydropyrimidine Dehydrogenase Genotype‐guided Fluoropyrimidine Dosing on Chemotherapy Associated Adverse Events." CTS: Clinical & Translational Science, vol. 14, no. 4, 2021, p. 1338, https://doi.org/10.1111/cts.12981.